Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Immune Pharmaceuticals Inc.

Headquarters: Englewood Cliffs, NJ, United States of America
Website: N/A
Year Founded: 2010
Status: Out of Business

BioCentury | Jul 29, 2021
Distillery Therapeutics

Pan-caspase inhibitor identified for bacterial skin infections

DISEASE CATEGORY: Infectious disease
INDICATION: Staphylococcus; Streptococcus; Pseudomonas A team at Johns Hopkins University School of Medicine showed a pan-caspase inhibitor could treat
BioCentury | Nov 3, 2017
Financial News

Immune Pharma raises $18M in follow-on

BioCentury | Jul 14, 2017
Clinical News

Immune begins Phase I/II of Ceplene in CMML

BioCentury | Mar 17, 2017
Clinical News

Bertilimumab: Preliminary Ph II data

BioCentury | Jan 27, 2017
Company News

SATT Sud-Est, Immune Pharmaceuticals deal

BioCentury | Sep 26, 2016
Financial News

Immune Pharmaceuticals proposes private placement

BioCentury | Sep 12, 2016
Emerging Company Profile

Age factors

Why Alkahest thinks plasma factors are key to fighting age-related diseases
Items per page:
1 - 10 of 37